MCRB · Seres Therapeutics, Inc.

NasdaqHealthcareBiotechnology

Seres Therapeutics Inc Is A Clinical-Stage Biotechnology Company Focused On The Development Of Live Biotherapeutic Candidates. Its Pipeline Includes Candidates Such As Ser-155 And Ser-603, Aimed At Preventing And Treating Bacterial Infections, Antimicrobial Resistance, And Gastrointestinal Immune Diseases. The Company Operates As A Single Reportable Segment, Mainly Developing Microbiome-Based Therapies Targeting Bacterial Infections, Antimicrobial Resistance, And Gastrointestinal Immune Diseases.

HealthcareNasdaqUSLow Float

FLOAT

7.1M

FREE FLOAT %

70%

SHARES O/S

10.0M

MARKET CAP

$21.0M

EXCHANGE

Nasdaq

COUNTRY

MCRB Catalyst History

No catalysts recorded for MCRB yet

Day Trader Sniper hasn't classified a publishable catalyst for MCRB yet. New events appear here as they're scored.

Be early on the next MCRB spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

MCRB · Seres Therapeutics, Inc.

MCRB Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.